MOLECULAR PARTNERS N/ CH0256379097 /
| 2024-04-17 5:31:23 PM | Chg. -0.0050 | Volume | Bid6:30:02 AM | Ask6:30:02 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 3.3750CHF | -0.15% | 9,847 Turnover: 33,183.7500 |
3.3300Bid Size: 750 | -Ask Size: 550 | 122.7 mill.CHF | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -1.89 CHF | -152.07% |
| EPS Diluted: | - CHF | - |
| Revenues per Share: | 0.19 CHF | -96.32% |
| Book Value per Share: | 4.85 CHF | -25.62% |
| Cash Flow per Share: | -1.62 CHF | - |
| Dividend per Share: | - CHF | - |
| Total | in mill. | |
| Revenues: | 7.04 CHF | -96.29% |
| Net Income: | -61.98 CHF | -152.59% |
| Operating Cash Flow: | -59.01 CHF | - |
| Cash and Cash Equivalents: | 67.31 CHF | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 17.43 | 17.77 |
| P/BV ratio: | 0.70 | 0.71 |
| P/CF Ratio: | -2.08 | -2.12 |
| PEG: | 0.01 | - |
| Earnings Yield: | -56.00% | -54.94% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 122.7 mill. CHF | 125.06 mill. CHF |
| Free Float Market Cap.: | - CHF | - CHF |
| Market Cap. / Employee: | 674,152.4856 CHF | 687,136.1631 CHF |
| Shares Outstanding: | 36.35 mill. | |
Profitability
| Gross Profit Margin: | 275.11% |
| EBIT Margin: | -868.26% |
| Net Profit Margin: | -880.70% |
| Return on Equity: | -35.13% |
| Return on Assets: | -31.25% |
Financial Strength
| Liquidity I / Cash Ratio: | 466.90% |
| Liquidity II / Quick Ratio: | 480.45% |
| Liquidity III / Current Ratio: | 1,335.04% |
| Debt / Equity Ratio: | 12.43% |
| Dynam. Debt / Equity Ratio: | -37.15% |
Efficiency
| Employees: | 182 |
| Personal Expenses / Employee: | - CHF |
| Revenues / Employee: | 38,670.33 CHF |
| Net Income / Employee: | -340,571.43 CHF |
| Total Assets / Employee: | 1,089,846.15 CHF |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | CHF |
